【レポートの概要（一部）】
Table of Content
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Driver Analysis
4.3. Market Restraint Analysis
4.4. Penetration & Growth Prospect Mapping
4.5. SWOT Analysis, By Factor
4.5.1. Political
4.5.2. Economic
4.5.3. Technological
4.6. Industry Analysis – Porter’s
4.7. Competitive Landscape & Market Share Analysis, 2015 & 2030
4.8. Liquid Biopsy Pipeline Analysis, 2015 – 2020
Chapter 5. Market Categorization 1: Application Estimates & Trend Analysis
5.1. Application Movement Analysis & Market Share, 2015, 2020 & 2030
5.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following applications:
5.2.1. Therapy Selection for Metastatic Breast Cancer (MBS)
5.2.2. Therapy Selection for Other Metastatic Cancer
5.2.3. Molecular Health Monitoring
Chapter 6. Market Categorization 2: Sample Type Estimates & Trend Analysis
6.1. Sample Type Movement Analysis & Market Share, 2015, 2020 & 2030
6.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following sample types:
6.2.1. Blood Samples
6.2.2. Urine Samples
6.2.3. Other Bio fluids (Tissue fluids and Saliva)
Chapter 7. Market Categorization 3: Biomarker Estimates & Trend Analysis
7.1. Biomarker Movement Analysis & Market Share, 2015, 2020 & 2030
7.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following biomarkers:
7.2.1. Circulating Tumor Cells (CTC)
7.2.2. Circulating Tumor DNA (ctDNA)
7.2.3. Exosomes (Macrovesicles with Protein, RNA, DNA)
Chapter 8. Market Categorization 4: Technology Estimates & Trend Analysis
8.1. Technology Movement Analysis & Market Share, 2015, 2020 & 2030
8.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following technologies:
8.2.1. Multi-gene parallel Analysis using NGS
8.2.2. Single Gene Analysis using PCR Microarrays
Chapter 9. Market Categorization 3: Regional Estimates & Trend Analysis
9.1. Regional Movement Analysis & Market Share, 2015, 2020 & 2030
9.2. North America
9.2.1. North America revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. North America revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.2.2.1. U.S.
9.2.2.2. Canada
9.2.3. North America revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.2.3.1. U.S.
9.2.3.2. Canada
9.2.4. North America revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.2.4.1. U.S.
9.2.4.2. Canada
9.3. Europe
9.3.1. Europe revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.3.1.1. Germany
9.3.1.2. UK
9.3.2. Europe revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.3.2.1. Germany
9.3.2.2. UK
9.3.3. Europe revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.3.3.1. Germany
9.3.3.2. UK
9.3.4. Europe revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.3.4.1. Germany
9.3.4.2. UK
9.4. Asia Pacific
9.4.1. Asia Pacific revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.4.1.1. Japan
9.4.1.2. China
9.4.2. Asia Pacific revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.4.2.1. Japan
9.4.2.2. China
9.4.3. Asia Pacific revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.4.3.1. Japan
9.4.3.2. China
9.4.4. Asia Pacific revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.4.4.1. Japan
9.4.4.2. China
9.5. Latin America
9.5.1. Latin America revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.5.1.1. Brazil
9.5.2. Latin America revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.5.2.1. Brazil
9.5.3. Latin America revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.5.3.1. Brazil
9.5.4. Latin America revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.5.4.1. Brazil
9.6. Middle East & Africa
9.6.1. Middle East & Africa revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.6.1.1. South Africa
9.6.2. Middle East & Africa revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.6.2.1. South Africa
9.6.3. Middle East & Africa revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.6.3.1. South Africa
9.6.4. Middle East & Africa revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.6.4.1. South Africa
Chapter 10. Competitive Landscape
10.1. Adaptive Biotechnologies
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiatives
10.2. Biocept
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Strategic Initiatives
10.3. Guardant Health
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Strategic Initiatives
10.4. NeoGenomics Laboratories
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Strategic Initiatives
10.5. Personal Genome Diagnostics
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Strategic Initiatives
10.6. Qiagen
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Strategic Initiatives
10.7. RainDance Technologies
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Strategic Initiatives
10.8. Trovagene
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Strategic Initiatives
10.9. Cynvenio
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Strategic Initiatives
10.10. Epic Sciences
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Strategic Initiatives
10.11. Exosome
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Strategic Initiatives
10.12. Foundation Medicine
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Strategic Initiatives
10.13. Genomic Health
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Strategic Initiatives
10.14. Illumina Inc.
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.4. Strategic Initiatives
10.15. Angle Plc
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Strategic Initiatives
10.16. Boreal Genomics
10.16.1. Company Overview
10.16.2. Financial Performance
10.16.3. Product Benchmarking
10.16.4. Strategic Initiatives
10.17. CareDx
10.17.1. Company Overview
10.17.2. Financial Performance
10.17.3. Product Benchmarking
10.17.4. Strategic Initiatives
10.18. Chronix Biomedical
10.18.1. Company Overview
10.18.2. Financial Performance
10.18.3. Product Benchmarking
10.18.4. Strategic Initiatives
10.19. Cynvenio Biosystems Inc.
10.19.1. Company Overview
10.19.2. Financial Performance
10.19.3. Product Benchmarking
10.19.4. Strategic Initiatives
10.20. Epic Sciences
10.20.1. Company Overview
10.20.2. Financial Performance
10.20.3. Product Benchmarking
10.20.4. Strategic Initiatives
10.21. Foundation Medicine
10.21.1. Company Overview
10.21.2. Financial Performance
10.21.3. Product Benchmarking
10.21.4. Strategic Initiatives
10.22. Natera Inc.
10.22.1. Company Overview
10.22.2. Financial Performance
10.22.3. Product Benchmarking
10.22.4. Strategic Initiatives
10.23. Pathway Genomics
10.23.1. Company Overview
10.23.2. Financial Performance
10.23.3. Product Benchmarking
10.23.4. Strategic Initiatives
10.24. Roche (Ariosa)
10.24.1. Company Overview
10.24.2. Financial Performance
10.24.3. Product Benchmarking
10.24.4. Strategic Initiatives
10.25. Sequenom
10.25.1. Company Overview
10.25.2. Financial Performance
10.25.3. Product Benchmarking
10.25.4. Strategic Initiatives
10.26. Trovagene
10.26.1. Company Overview
10.26.2. Financial Performance
10.26.3. Product Benchmarking
10.26.4. Strategic Initiatives
【レポート販売概要】
■ タイトル：液体生検の世界市場分析：用途別（転移性乳がん（MBS）の治療選択、他の転移性がんの治療選択、分子モニタリング、分子モニタリング）、サンプル別（血液、尿、組織および唾液）、バイオマーカー別（循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、エキソソーム）、技術別（単一遺伝子解析（PCRマイクロアレイ）、多遺伝子並列分析（NGS））、動向分析、2013-2030■ 英文：Liquid Biopsy Market Size & Forecast By Application (Therapy Selection for Metastatic Breast Cancer (MBS), Therapy Selection for Other Metastatic Cancers, Molecular Monitoring, Molecular Monitoring), By Sample Type (Blood, Urine, Tissue & Saliva), By Biomarker Type (Circulating Tumor Cells (CTC), Circulating Tumor DNA (ctDNA), Exosomes), By Technology (Single Gene Analysis (PCR Microarrays), Multi-gene-parallel Analysis (NGS)) And Trend Analysis from 2013 To 2030
■ 発行日：2016年9月8日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707486
■ 調査対象地域：グローバル
- 甲状腺濾胞がん(Follicular Thyroid Cancer)の治療薬パイプライン動向（2015年上半期版）Follicular Thyroid Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Follicular Thyroid Cancer - Pipeline Review, H1 2015’, provides an overview of the Follicular Thyroid Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Follicular Thyroid Cancer, complete with comparative analysis at various stages, therapeutics asse …
- Diabetic Gastroparesis：グローバル臨床試験レビューH1, 2013Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013" provides data on the Diabetic Gastroparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Gastroparesis. It includes an overview of the trial numbers and …
- 世界の自動車用スピーカー市場2015The Global Automotive Speaker Industry Report 2015 is a professional and in-depth study on the current state of the Automotive Speaker industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Speaker market analysis is provided for the international markets including development trends, competiti …
- 世界のNTCサーミスタ市場2015The Global Negative Temperature Coefficient (NTC) Thermistors Industry Report 2015 is a professional and in-depth study on the current state of the Negative Temperature Coefficient (NTC) Thermistors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Negative Temperature Coefficient (NTC) Thermistors m …
- ヘリコプターの世界市場予測：POS別、OEM種類別、OEM用途別、OEMコンポーネント＆システム別Increased demand for military helicopters is expected to drive the growth of helicopters market.The helicopters market is projected to grow from USD 31.7 billion in 2019 to USD 37.4 billion by 2025, at a CAGR of 2.8% during the forecast period. The development of next-generation helicopters is one of the significant factors driving the growth of the market. In addition, increased automation, techn …
- 北米の鉄道車両市場ABSTRACTAbout Rolling Stock Rolling stock refers to wheeled railway vehicles that move on tracks; for example, locomotives, passenger rail vehicles, and freight wagons. It includes both self-propelled and externally propelled vehicles. Technavio’s analysts forecast the rolling stock market in North America to grow at a CAGR of 4.07% during the period 2017-2021. [Covered in this report] The report …
- 世界及び中国のシクロヘキサンジメタノ—ル(CHDM)市場2015The Global Cyclohexane Dimethanol (CHDM) Industry Report 2015 is a professional and in-depth study on the current state of the global cyclohexane Dimethanol industry. The report provides a basic overview of the industry including definitions, classifications, applications, industry chain structure and overview. CHDM market status analysis is provided on both an international basis as well as at ma …
- 加湿器の世界市場：ウォームミスト加湿機、クールミスト加湿機、超音波式加湿機About humidifier A humidifier is a device that helps to regulate humidity level in enclosed spaces and add moisture to the air when the humidity falls. Humidifier is used for residential, commercial, as well as industrial applications. It is categorized into portable and whole-house humidifier. The following are the three types of humidifiers: warm mist humidifier, ultrasonic humidifier, and cool …
- 骨の悪性線維性組織球腫：グローバル臨床試験レビュー（2014年上半期）Malignant Fibrous Histiocytoma Of Bone Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Malignant Fibrous Histiocytoma Of Bone Global Clinical Trials Review, H1, 2014" provides data on the Malignant Fibrous Histiocytoma Of Bone clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Fibrous Histio …
- コンピュータビジョンの世界市場展望2017-20276According to Stratistics MRC, the Global Computer Vision market is accounted for $11.04 billion in 2017 and is expected to reach $23.78 billion by 2026 growing at a CAGR of 8.9% during the forecast period. Increasing need for quality inspection and automation, rising demand for vision-guided robotic systems and high adoption of 3d computer vision systems are the major factors driving the market gr …
- ARゲームの世界市場2017-2021About AR Gaming The first stage of AR began in the late 1950s when Sensorama was invented. The machine was similar to a mini theater that would engage all five senses and create an immersive experience at the cinema. Since the invention of Sensorama, many ideas that could enable people to interact with their environment have come up. One such is the virtual reality (VR) technology that creates a s …
- 世界の工作機械市場（2014-2018）About Machine Tool Machine tools, such as metal cutting tools, metal forming tools, and machine tools accessories, are used to cut and shape metals and other materials during the manufacturing of a product based on its specifications. These tools provide an effective and efficient method of manufacturing critical components with the utmost ease and accuracy. Machine tools are used extensively by c …
- 院内感染症治療薬の世界市場：尿路感染症、気道感染症、血流感染症、手術部位感染症、胃腸感染症About hospital-acquired infections Hospital-acquired diseases are also known as nosocomial infections that are acquired in hospitals and other healthcare facilities. These infections are classified only when a patient is admitted for reasons other than the infections and are caused by bacteria, fungi, parasites, or viruses. Most common types of hospital-acquired infections are SSIs, UTIs, bloodstr …
- German Hospital Infectious Disease Testing Market 2014This new report from Venture Planning Group contains 897 pages, 74 tables, and presents a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. …
- 世界のクレーン（建設機械）市場（2014-2018）About Crane Market The Construction Equipment market has experienced several pits and falls in the past decade due to global economic recession. Crane market forms an integral part of the Construction Equipment market and has co-witnessed the market falls. There are broadly three types of cranes: mobile cranes, marine, and port cranes and fixed cranes. Cranes can be categorized as per their load l …
